The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment

<div>Receiver Operating Characteristic (ROC) curve of NK cells in different stages of CRC cases (stages 1&amp;2 vs. stages 3&amp;4).</div>

Disease Markers

fig3

Figure 3

Figure 3: The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment 

Figure 3 | The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment 